Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

81.58
Delayed Data
As of Feb 16
 +0.24 / +0.30%
Today’s Change
27.24
Today|||52-Week Range
95.91
+39.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash30.7M21.7M16.6M65.7M
 
 
 
 
 
Short Term Investment Cash21.8M-9.0M-5.1M49.1M
 
 
 
 
 
Cash & Short Term Investments90.8M145.2M210.1M223.7M
 
 
 
 
 
 
ReceivablesReceivables4.5M15.7M12.8M10.6M
 
 
 
 
 
 
InventoriesInventories----0.000.00--
 
Current AssetsOther Current Assets12.7M9.7M9.2M3.5M
 
 
 
 
 
Current Assets108.0M170.6M232.2M237.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.9M10.2M13.1M15.1M
 
 
 
 
 
Depreciation-4.1M-4.3M-5.1M-7.1M
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets155.4M246.0M281.4M327.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M1.5M3.4M3.7M
 
 
 
 
 
Short Term Debt0.0069.0K73.0K79.0K
 
 
 
 
Accrued Expenses1.6M964.0K2.1M5.1M
 
 
 
 
 
Other Current Liabilities1.6M2.3M2.1M5.1M
 
 
 
 
 
Other Liabilities4.7M6.7M7.9M21.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.00692.0K617.0K1.1M
 
 
 
 
Deferred Taxes-4.2M-4.6M-8.4M-10.1M
 
 
 
 
 
Other Liabilities1.7M1.9M1.9M1.5M
 
 
 
 
 
Total Liabilities6.6M9.9M11.4M26.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock202.0K0.000.00--
 
 
Common Equity148.7M236.2M269.9M301.7M
 
 
 
 
 
Total Shareholder Equity148.9M236.2M269.9M301.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding18.6M18.7M19.0M19.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.